Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 217.75
-2.25 (-1.02%)
At close: Jul 7, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 26.85 billion as of July 7, 2026. Its market cap has decreased by -42.09% in one year.
Market Cap
26.85B
Enterprise Value
33.55B
Revenue
17.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
217.75
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 26.85B, an increase of 1,878.23%. That is a compound annual growth rate of 13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 26.85B | -4.03% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 53.55B |
| Gufic Biosciences | 37.61B |
| Novartis India | 36.27B |
| Unichem Laboratories | 32.67B |
| Morepen Laboratories | 32.32B |
| Kwality Pharmaceuticals | 27.77B |
| Venus Remedies | 22.89B |
| Amrutanjan Health Care | 15.52B |